The urgent need for designing greener drugs

Tomas Brodin, Michael G. Bertram, Kathryn E. Arnold, Alistair B.A. Boxall, Bryan W. Brooks, Daniel Cerveny, Manuela Jörg, Karen A. Kidd, Unax Lertxundi, Jake M. Martin, Lauren T. May, Erin S. McCallum, Marcus Michelangeli, Charles R. Tyler, Bob B.M. Wong, Klaus Kümmerer, Gorka Orive

Research output: Contribution to journalComment / DebateOtherpeer-review

13 Citations (Scopus)

Abstract

The pervasive contamination of ecosystems with active pharmaceutical ingredients poses a serious threat to biodiversity, ecosystem services and public health. Urgent action is needed to design greener drugs that maintain efficacy but also minimize environmental impact.

Original languageEnglish
Pages (from-to)949–951
Number of pages3
JournalNature Sustainability
Volume7
DOIs
Publication statusPublished - 5 Jun 2024

Cite this